Developing a machine learning algorithm to detect undiagnosed pertussis episodes
Quinten Health has developed a machine learning algorithm to identify misdiagnosed or undiagnosed episodes of whooping cough in patients diagnosed with acute respiratory illness. The team used elements from clinician notes such as observed symptoms, and demographic information from electronic care records from Optum Humedica, a US population-based database. Although tetanus-diphtheria-acellular pertussis (Tdap) vaccines for […]
Quinten Health’s poster selected for presentation at AFCROs’ symposium
Quinten Health’s team presented their poster “Artificial intelligence for real-life disease modeling: vision, examples and impact on drug evaluation” at the 15th edition of the AFCROs’ symposium on Real-World health data. Marie Génin & Sam Ekhtiari were there on June 20th to represent the team where the poster was displayed.Billy Amzal, Antoine Movschin, Mélissa Rollot, […]
Machine Learning (ML) applied to real-world data to guide prescription of immune-therapies in metastatic melanoma: a pilot study
Event: ISPOR Global 2023, Boston, MA, USA Authors: F. Gwadry-Sridhar, Billy Amzal View Poster Objectives: Newly diagnosed metastatic melanoma patients are often treated with molecular targeted therapy (TT) or with immunotherapy (IO). However, only a limited proportion of patients respond to those therapies, resulting in reduced survival and substantial inefficiencies for health systems. The purpose […]
“Securing & accelerating clinical development and market access for therapeutic innovations using Real-World disease and care modeling and simulation”
Alexandre Templier, President of Quinten Health, was invited last Thursday by Norbert Nabet (Ziwig Biotech) to take part in a round table organized by E4i. The theme of the round table was innovative therapies related to precision medicine. Alexandre Templier spoke about how real-world data (RWD) is set to revolutionize the clinical development and market […]
We will speak at BiotechX 2022
Quinten Health will be at the Biotech X 22 at Basel Congress Center, Switzerland. Alexandre Templier (President and co-founder) and Frank Ahrens (Chief Commercial Officer) will be at BioTechX 22 in Basel, Switzerland on November 8th to 10th, 2022. You will be able to meet them there, and assist to Alexandre’s talk about “Combining RCT […]
Projeter l’efficacité d’un traitement en vie réelle (VR) à partir d’une étude clinique randomisée (ECR) : une approche utilisant le suréchantillonnage
Event: 11ème Colloque Données de Santé en vie réelle 2019, AFCROs, Paris, France Authors: C. Esnault, M. Génin, S. Ekhtiari, A. Civet View Poster Introduction Bien qu’il n’y ait pas encore de consensus formel sur l’emploi des modèles statistiques pour estimer l’efficacité d’un traitement en VR, le besoin de son évaluation plus systématique est largement reconnu [1] […]
